期刊文献+

阿尔茨海默病不同临床阶段脑脊液中炎前和抗炎细胞因子水平的变化 被引量:2

Pro-and anti-inflammatory cytokines in cerebrospinal fluid of patients with Alzheimer's disease
下载PDF
导出
摘要 目的:观察不同临床阶段阿尔茨海默病(AD)患者脑脊液中炎前和抗炎细胞因子水平与神经病理损伤的关系。方法:用夹心式酶联免疫吸附法测定轻、中、重度AD患者,血管性痴呆(VD)患者与正常老年人脑脊液中白介素-1β(IL-1β)、肿瘤坏死因子α(TNFα)和白介素1受体拮抗剂(IL-1ra)的水平。结果:各AD组患者脑脊液中IL-1β、TNFα的水平较其他组有不同程度升高,而IL-1ra则有不同程度降低,各AD组组间比较,随着痴呆程度的加重,IL-1β与TNFα水平相应增高,IL-1ra却相应下降,其中重度AD患者这种改变与轻度AD患者比较差异有显著性(P<0.05)。结论:炎前和抗炎细胞因子表达失衡造成的级联反应在AD脑损害过程中起重要作用。 Objective: To investigate the relationship between the levels of pro- and anti-inflammatory eytokines and the neuropatbological damage in different clinical stages of Alzheimer's disease (AD). Methods: The levels of interleukin-1 β (IL-1 β), interleukin-1 receptor antagonist (IL-1ra) and tumor necrosis factor-α (TNF-α) in the cerebrospinal fluid (CSF) were determined by ELISA in 45 patients with AD, 30 patients with vascular dementia (VD) and 25 normal subjects. Rcsults: Compared with VD and control groups, IL-1 β and TNF-α contents increased, and IL-1ra concentration decreased in AD group. Levels of 1L-1 β and TNF-α were upregulated and that of IL-1ra downregulated with the aggravation of dementia. There was a significant difference m the change of thesecytokines between late stage and early stage of AD patients (P〈0.05). Conclusion: The cascade reaction due to the imbalance of pro- and anti-inflammatory cytokines may play important roles in the brain damage in AD.
出处 《广东医学院学报》 2006年第4期349-350,共2页 Journal of Guangdong Medical College
基金 广东省湛江市科委科技计划项目基金(No.2004-2)
关键词 阿尔茨海默病 肿瘤坏死因子 白介素1受体拮抗剂 白介素1Β Alzheimer's disease: interleukin-1β interleukin-1 receptor antagonist: tumor necrosis factor-α
  • 相关文献

参考文献6

  • 1AKIYAMA H,BARGER S,BARNUM S,et al.Inflammation and Alzheimer's disease[J].Neurobiol Aging,2000,21:383-421.
  • 2KEITH T,LINDA J,VAN E.Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1 beta and tumor necrosis factor-a (TNFα)-dependent,and involves a TNFα receptor-associated factor-and NFκB-inducing kinase-dependent signaling mechanism[J].J Biol Chem,2000,275 (11):7918-7924.
  • 3吴传深,周东丰,管振全.血浆IL-6水平与阿尔茨海默病[J].中国神经免疫学和神经病学杂志,2003,10(2):87-89. 被引量:8
  • 4TARKOWSKI E,LILJEROTH A M,MINTHON L,et al.Cerebral pattern of pro-and anti-inflammatory cytokines in dementias[J].Brain Res Bull,2003,61(3):255-260.
  • 5TARKOWSKI E,LILJEROTH A M,NILSSON A,et al.Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease[J].Dement Geriatr Cogn Disord,2001,12 (5):314-317.
  • 6SHEN J G,ITO K,SKINNER R D,et al.In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer's pathogenesis[J].Neurobiol Aging,1996,17:761-766.

二级参考文献9

  • 1[1]Strauss S,Bauer J,Ganter U,et al. Detction of interleukin-6 and alpha-2 macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients[J]. Lab Invest, 1992,66(2):223-230.
  • 2[2]Huell M,Strauss S,Volk B,et al. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients[J]. Acta Neuropathol(berl), 1995,89(6):544-551.
  • 3[3]Bonaccorso S,Lin A,Song C,et al. Seroto-nine-immune interactions in elderly volunteers and in patients with Alzheimer's disease DAT: lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT[J]. Aging (Milano), 1998,10: 316-323.
  • 4[4]Angelis P,Scharf S,Mander A,et al. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease[J]. Neurosci Lett, 1998,244(2):106-108.
  • 5[5]Alvarez XA,Franco A,Fernandez-Novoa F,et al. Blood levels of histamine, IL-1 beta and TNF-alpha in patients with mild to moderate Alzheimer's disease[J]. Mol Chem Neuropathol, 1996,29:237-252.
  • 6[6]McGeer PL,Schulzer M,McGeer EG.Arthritis and anti-in-flammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies[J]. Neurology, 1996,47:425-432.
  • 7[7]Mrak RE,Sheng JG,Griffin ST.Glial cytokines in Alzheimer's disease: review and pathogenetic implications[J]. Hum Pathol, 1995,26:816-823.
  • 8[8]Hampel H,Schoen D,Schwarz MJ,et al. Interleukin-6 is not altered in cerebrospinalfluid of first-degree relatives and patients with Alzheimer's disease[J]. Neurosci Lett, 1997,228:143-146.
  • 9[9]Lanzrein AS,Johnston CM,Perry VH,et al. Longitudinal study of inflammatory factors in serum, cerebrospinalfluid,and brain tissue in Alzheimer's disease: interleukin-beta1, interleukin-6, interleu-kin-1 receptor antagonist,tumor necrosis factor-alpha,the soluble tumor necrosis factor receptors Ⅰ and Ⅱ, and alpha1-antichymotrypsin[J]. Alzheimer Dis Assoc Disord, 1998,12:215-227.

共引文献7

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部